30th Nov 2007 11:18
Hikma Pharmaceuticals Plc30 November 2007 Hikma Pharmaceuticals PLC - Voting Rights and Capital LONDON, 30 November 2007: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)notifies the market that as at 30 November 2007 its capital consists of170,584,607 ordinary shares with voting rights. There are no shares held intreasury. The above figure (170,584,607) may be used by shareholders as the denominatorfor the calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Hikma Pharmaceuticals PLCunder the FSA's Disclosure and Transparency Rules. - ENDS - Enquiries: Hikma Pharmaceuticals PLCHenry Knowles +44 20 7399 2760Company Secretary About Hikma Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: Generic, Branded and InjectablePharmaceuticals. Hikma's operations are based principally in the United States,the Middle East and North Africa ("MENA") region and Europe. In 2006, the Grouphad revenue of $317 million and profit attributable to shareholders of $54.5million. For news and other information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals